NCT01050127View on ClinicalTrials.gov

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ABT-436 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

February 28, 2010

Conditions
Healthy
Interventions
DRUG

ABT-436

See Arm Description for details.

DRUG

Placebo

See Arm Description for details.

Trial Locations (1)

60085

Site Reference ID/Investigator# 24849, Waukegan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY